Pharmacokinetics, Pharmacodynamics, and Tolerability of Olpasiran in Healthy Japanese and Non-Japanese Participants: Results from a Phase I, Single-dose, Open-label Study
- Resource Type
- Article
- Source
- In
Clinical Therapeutics September 2022 44(9):1237-1247 - Subject
- Language
- ISSN
- 0149-2918